LipoX

One of the most significant challenges in gene therapy is delivering genetic materials effectively to their target within the body.

The LipoX team is currently in the process of developing a product called lipid nanoparticles (LNPs) to address this challenge. These LNPs will efficiently and selectively transport gene-based therapies throughout the body.

Researchers: Abdalla Ali, Stanislav Kan & Wei Zhao

Faculty of Medicine, Dentistry and Health Sciences

Information